Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria

MLA

Lee, Kwan Yong, et al. “Clinical Benefit of Long-Term Use of Dual Antiplatelet Therapy for Acute Myocardial Infarction Patients with the PEGASUS-TIMI 54 Criteria.” Frontiers in Cardiovascular Medicine, vol. 9, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b4be71697ef8b8c8e830318371931ff&authtype=sso&custid=ns315887.

APA

Lee, K. Y., Hwang, B.-H., Choo, E.-H., Lim, S., Kim, C. J., Kim, J.-J., Byeon, J., Choi, I. J., Oh, G. C., Choi, Y. S., Yoo, K. D., Chung, W. S., Ahn, Y., Jeong, M. H., & Chang, K. (2022). Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria. Frontiers in Cardiovascular Medicine, 9.

Chicago

Lee, Kwan Yong, Byung-Hee Hwang, Eun-Ho Choo, Sungmin Lim, Chan Jun Kim, Jin-Jin Kim, Jaeho Byeon, et al. 2022. “Clinical Benefit of Long-Term Use of Dual Antiplatelet Therapy for Acute Myocardial Infarction Patients with the PEGASUS-TIMI 54 Criteria.” Frontiers in Cardiovascular Medicine 9 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b4be71697ef8b8c8e830318371931ff&authtype=sso&custid=ns315887.